Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1...
Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1 ‐rearranged non‐small cell lung cancer
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
A 75‐year‐old woman was referred to our hospital because of a productive cough and an abnormal shadow on chest radiography. She was diagnosed as having metastatic lung adenocarcinoma harbouring ROS proto‐oncogene 1 (
ROS1
). First‐line therapy was instituted with entrectinib 600 mg daily, and a gradual decrease in serum sodium level was notic...
Alternative Titles
Full title
Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1 ‐rearranged non‐small cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_07c6a49c57584e118620bc982b62f098
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07c6a49c57584e118620bc982b62f098
Other Identifiers
ISSN
2051-3380
E-ISSN
2051-3380
DOI
10.1002/rcr2.1217
